Company overview
10x Genomics provides single-cell and spatial transcriptomics technologies, including Chromium systems for high-throughput gene expression profiling and GEM-based barcoding of thousands of cells. Their Visium and Xenium platforms enable spatial biology analysis with whole transcriptome profiling and subcellular RNA localization. These tools support pharma R&D in cell heterogeneity, biomarker discovery, immune profiling, and AI-driven drug development.
Decoding Biology. Transforming Health. is listed in the NovaPharmaNews Supplier Hub as a Diagnostics & Testing partner serving United States & Americas. Core focus areas include 10x genomics, single cell sequencing, spatial transcriptomics, chromium system, visium platform.
Industry categories: Diagnostics & Testing. These tags help R&D, manufacturing, and procurement teams discover vendors aligned with their pipeline stage and compliance requirements.
Structured facts
- Website
- https://www.10xgenomics.com
- Categories
- Diagnostics & Testing
- Markets served
- United States & Americas
- Keywords
- 10x genomics, single cell sequencing, spatial transcriptomics, chromium system, visium platform
Products & technologies
Markets served
Industry categories
Company timeline
- — Profile published on NovaPharmaNews
- — Profile last updated
Related suppliers in category
Frequently asked questions
- What single-cell capabilities does 10x Genomics offer?
- Chromium systems enable transcriptional profiling, CNV analysis, V(D)J immune sequencing, and feature barcoding for surface proteins across thousands of cells per run using GEM technology.
- What spatial biology solutions are available?
- Visium provides NGS-based whole transcriptome tissue profiling; Xenium offers in situ imaging for thousands of RNA targets with subcellular resolution.
- What are the key advantages for high-throughput analysis?
- High cellular throughput up to 80,000 cells per run, 50,000 reads per cell coverage, and scalable multi-omics including gene expression, ATAC-seq, and protein detection.
Related editorial coverage
- $2M Gene Therapy Cures Need a Financing Model
- A Secure And Intelligent Drug Delivery Model Integrating Neural Networks With Blockchain
- AACR 2024: Daily Oncology Research Roundup
- AACR 2024: Oncology News & Key Takeaways - Day 1
- AACR 2024: Oncology Research Highlights - Day 1 Roundup
- AACR 2026: AI Pathology & Oncolytic Virus Spark Interest
Explore lab tools and QA/QC resources for R&D teams.
